Concord Biotech Ltd (CONCORDBIO)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1590.00
% Change: -1.54% (Prev Close: 1614.90)

Volume: 1,27,714
% Change: 161.21% (Prev Volume: 48,893)

Delivery: 60,525
Delivery % : 47.39
% Change: 124.44% (Prev Delivery: 26,967)

Turnover: 2,033 Lacs
% Change: 154.83% (Prev Turnover: 798)

πŸ’Ή EOD Valuation

P/E Ratio: 46.71
P/B Ratio: 9.18
Market Cap: 16631 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: CONCORDBIO
Market Cap: 17593 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 2664.00
52 Week Low: 1345.00

All-Time High: 2664.00 Rs.
All-Time Low: 900.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-0.16% | -11.82% | -1.54% | -4.95% | 0.00%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 44.08%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 9.10%

Change (3Y | 1Y): 0.00% | -0.25%

DII Holding

DII Holding: 8.85%

Change (3Y | 1Y): 0.00% | -0.31%

Public Holding: 37.94%

🏦 Financial Strength

Debt to Equity: 0.00
Debt: 2.97 Rs. Cr.

Book Value: 173.27 Rs.
Current Ratio: 4.45
Interest Coverage: 1317.03
Free Cash Flow: 133.55 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 14.49%

Sales Growth Qtr (YOY | QoQ):
-5.47% | -52.55%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
18.56% | 18.96% | 14.49%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 13.70%

Profit Growth Qtr (YOY | QoQ):
-26.06% | -68.62%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
18.55% | 27.56% | 13.70%

EPS Rs.

EPS (TTM): 34.04 Rs.

EPS Qtr (Last Year | Latest):
5.70 Rs. | 4.21 Rs.

EPS Annual (Last Annual | Annual March):
29.45 Rs. | 35.52 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-26.61% | -42.65%

Net Profit Rs. Cr.

Net Profit (TTM): 356.11 Rs. Cr.

Net Profit (Annual - March): 371.64 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
59.59| 140.39 | 44.06

EBITDA Rs. Cr.

EBITDA (Quarter): 76.57 Rs. Cr.
EBITDA (Previous Yr Ql): 92.94 Rs. Cr.

EBITDA (Annual - March): 527.93 Rs. Cr.
EBITDA (Previous Annual): 455.26 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
19.95% | 22.31%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 40.56%

OPM Qtr (Previous | Current):
43.94% | 30.10%

OPM Annual (5 Yrs | Last Yr | March):
42.73% | 42.50% | 42.14%

Return on Equity %

ROE: 21.27%

ROE (5 Yrs | 3 Yrs | Last Yr):
20.79% | 20.82% | 21.13%

Return on Capital Employed %

ROCE: 28.25%

ROCE (5 Yrs | 3 Yrs | Last Yr):
27.16% | 27.46% | 28.11%

Return on Assets %

ROA (TTM): 19.01%

ROA (5 Yrs | 3 Yrs | Last Yr):
17.94% | 18.11% | 18.51%

PEG Ratio: 1.79
Dividend Yield: 0.64%

PE 3 Yrs: 54.24
PE 5 Yrs: 54.24

Dividend Yield: 0.64%

πŸ‘₯ Company

Concord Biotech Ltd

CONCORDBIO

Promoter Holding: %